Myasthenia gravis: Association of British Neurologists’ management guidelines
Other content recommended for you
- Extraocular muscle responses to high dose intravenous methylprednisolone in myasthenia gravis
- Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan
- Update on myasthenia gravis
- Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment
- When the patient fails to respond to treatment: myasthenia gravis
- Myasthenia gravis and other neuromuscular junction disorders
- Myasthenia and related disorders of the neuromuscular junction
- A case of diplopia and arm weakness
- THE NEUROMUSCULAR JUNCTION DISORDERS
- Anti-MuSK antibodies in a case of ocular myasthenia gravis
Jump to comment:
I am grateful to Drs Wong and Plant for their invaluable comments, based on their enormous experience of patients presenting with suspected ocular myasthenia. The Guidelines are intended to offer non-specialists an approach to management that will work, safely, in the majority of patients. Within them, we stressed repeatedly the need to seek specialist opinion when in any doubt, and their letter emphasises the benefit of...
Dear Sirs, Myasthenia gravis: Association of British Neurologists' management guidelines We read with interest the ABN's management guidelines on Myasthenia Gravis and commend the authors for putting toget her guidelines for this condition where the evidence base is limited. The comments here reflect our experience of managing a large number of patients with ocular myasthenia gravis (OMG). Moor fields Eye Hospital is th...